Home | Publications | Diagnostics place holder
place holder place holder

Diagnostics

Innovations in Diagnostics


Publication Date   September 2006
Publisher   Business Insights
Product Type   Report
Pages   126
ISBN Number   not applicable
Product Code   RBI104
Ask a question about this product?

Price £1,495.00

approximately: $2,640 | €1,896

Summary


The global diagnostics market is undergoing radical change; novel technologies driven by miniaturization and advances in genomics will enhance the role of diagnostics in the healthcare market, allowing more tests to be performed at the point-of-care and facilitating the shift towards personalized medicine. "Innovation in Diagnostics" examines the advances in the rapidly growing field of molecular technologies that are enabling personalized healthcare to move into mainstream medicine. New opportunities in infectious disease testing, molecular oncology and pharmacogenomics are explored in detail, enabling you to understand the forces that are driving in vitro diagnostics (IVDs) into centre stage of the healthcare arena. Understand the changing relationship between IVD companies and the pharmaceutical industry, assess the convergence of IVDs and medical imaging, and develop an understanding of new technologies that will influence diagnostic product development and drug development programs.

Content


  • Introduction To Diagnostics
  • Challenges And Opportunities In Diagnostic Innovation
  • Molecular Technology Innovations
  • Innovation In Infectious Disease Diagnostics
  • Personalized Medicine
  • Point-Of-Care Testing
  • Competitive Landscape
  • Chapter 1 Introduction To Diagnostics
    • Summary
    • Introduction
    • The Global Ivd Market
    • Market Segments
    • Market Dynamics
    • Market Growth
    • Key Ivd Players
    • Industry Profile
    • Overview Of Diagnostic Technologies
    • Immunoassays
    • Nucleic Acid (Na) Assays
    • Biosensors
    • Microarrays
    • Future Trends
  • Chapter 2 Challenges And Opportunities In
    • Diagnostic Innovation
    • Summary
    • Introduction
    • A Changing Healthcare Environment
    • Challenges & Opportunities
    • Regulatory Hurdles
    • Reimbursement
    • Technology Requirements
    • Connectivity
    • Communication
    • New Partnerships/New Players
  • Chapter 3 Molecular Technology Innovations
    • Summary
    • Introduction
    • Ivd Technologies
    • Pcr
    • Fish
    • Arrays
    • Nanotechnology
    • Dna Methylation
    • Dna Biosensors
  • Chapter 4 Innovation In Infectious Disease
    • Diagnostics
    • Summary
    • Introduction
    • Emerging Infections
    • Avian Influenza H5n1
    • Sars
    • Multiple Detection Of Infectious Agents
    • Future Challenges
    • Hospital-Acquired Infections
    • Gonorrhea
    • Early Onset Sepsis
    • Other Infections
  • Chapter 5 Personalized Medicine
    • Summary
    • Introduction
    • Imaging: Part Of The Dx+Pgx+Rx Equation
    • Pharmacogenomics
    • Clinical Application Of Pharmacogenomics
    • Pharmacogenetic Tests
    • Case Study: Amplichip Cyp450
    • Other Pharmacogenetic Tests
    • Biomarkers
    • Case Study: Diabetes
    • Case Study: Heart Disease
    • Oncology
    • Breast Cancer
    • Colorectal Cancer
    • Leukemia
    • Lung Cancer
    • Prostate Cancer
    • Future Challenges
  • Chapter 6 Point-Of-Care Testing
    • Summary
    • Introduction
    • Blood Glucose Tests
    • Case Study: Scout Test For Diabetes Screening
    • Infectious Diseases
    • Rapid Step B Test
    • Urinary Tract Infection (Uti) Biosensor
    • Active Tuberculosis (Tb)
    • Cardiac Diagnostics
    • Blood Coagulation
    • Cardiac Markers
    • Direct Ldl Cholesterol Test
    • Stroke
    • Bladder Cancer Rapid Test
    • Hiv Home Tests
    • Future Challenges
  • Chapter 7 Competitive Landscape
    • Summary
    • Introduction
    • Key Mergers & Acquisitions
    • Competitive Landscape
    • Pharma Companies With Dx Divisions
    • Roche Diagnostics
    • Diabetes Care
    • Centralized Diagnostics
    • Molecular Diagnostics
    • Near Patient Testing
    • Applied Science
    • Product Pipeline
    • Abbott
    • Diabetes Care
    • Immunodiagnostics, Clinical Chemistry And Hematology
    • Molecular Diagnostics
    • Point-Of-Care
    • Medtech Companies With Dx Divisions
    • Becton Dickinson
    • Diagnostics
    • Biosciences
    • Dx Specialists
    • Gen-Probe
    • Clinical Diagnostics
    • Blood Screening
    • Molecular Diagnostics
    • Inverness Medical Innovations (Imi)
    • Consumer Diagnostics Products
    • Professional Diagnostics Products
    • Research & Development
    • Acquisitions
    • Tm Bioscience
    • Human Genetics
    • Infectious Disease
    • Pgx
    • Technology Specialists
    • Affymetrix
    • Collaborations
    • Competition
    • Nanogen
  • Chapter 8 Appendix
    • Index
  • List Of Figures
    • Figure 1.1: Ivd Market Segments, 2005
    • Figure 1.2: Ivd Market Segments Projected Growth, 2004-2010
    • Figure 3.3: Orion Genomics' Second Code Technology
    • Figure 5.4: The Healthcare Model Of The Future: Personalized Medicine
    • Figure 5.5: Breast Cancer Management In The Future
    • Figure 5.6: From Diagnostic Market Candidate To A Product: Three Development Phases
    • Figure 5.7: Potential Roles Of Genomics In Cancer
    • Figure 7.8: New Cancer Marker Launches
    • Figure 7.9: Gen-Probe Leads Us Std Market, 2002-05
    • Figure 7.10: Imi Product Sales By Business Segment, 2005
    • Figure 7.11: Imi's Leading Market Position In Consumer Diagnostics
  • List Of Tables
    • Table 1.1: Top 15 Ivd Companies, 2005
    • Table 2.2: Development Costs And Timeframes To Produce A New Ivd In The Us, 2006
    • Table 5.3: Cancer Markers Used In Dx Tests
    • Table 7.4: Pure-Play Diagnostic Companies And Ownership Of Ivd Companies By Medical Device And Pharmaceutical Companies
    • Table 7.5: Roche Diagnostics Sales, H1 2006
    • Table 7.6: Gen-Probe Product Sales, 2005